SCIENTIFIC
SCHEDULE |
||||||||||||||||
| Saturday, 3 December 2005 | Sunday, 4 December 2005 | |||||||||||||||
| BREAKFAST
SYMPOSIA 1
What to do in respiratory failure? |
MEET THE EXPERT | |||||||||||||||
| 08.00 - 08.20 | The
insights of respiratory failure |
08.00 - 09.00 | How to design and how to write a medical research | |||||||||||||
| 08.20 - 08.40 | Clinical approach in acute and chronic respiratory failure: The basics of oxygen therapy | |||||||||||||||
| 08.40 - 09.00 | The pulmonary cachexia syndrome & nutritional support in acute and chronic respiratory disease | INTERACTIVE
LECTURE Clinical judgments on blood gas analysis interpretations |
||||||||||||||
| 08.00 - 08.30 | introduction & brief lecture on blood gas analysis interpretation | |||||||||||||||
| BREAKFAST
SYMPOSIA 2 Severe respiratory infections and ARDS |
08.30 - 09.00 | Reviews of clinical judgments on blood gas analysis interpretation | ||||||||||||||
| 08.00 - 08.20 | Management of septicemia | |||||||||||||||
| 08.20 - 08.40 | Invasive pulmonary fungal infections | FREE PAPERS PRESENTATION | ||||||||||||||
| 08.40 - 09.00 | ARDS prevention and clinical management of severe pneumonia | 08.00 - 09.00 | ||||||||||||||
| 09.00 - 09.20 | Opening ceremony | |||||||||||||||
| PLENARY
SYMPOSIUM 2 Management of ARDS - Beyond the protocols |
||||||||||||||||
| PLENARY
SYMPOSIA 1 New insights in acute respiratory distress syndrome |
09.00 - 09.30 | Pharmacokinetic and pharmacodynamic of antibiotics in the lung | ||||||||||||||
| 09.20 - 10.00 | Pulmonary and extrapulmonary acute respiratory distress syndrome: Are they different? | 09.30 - 10.00 | Venfilatory & nonventilatory strategies in ARDS management | |||||||||||||
| 10.00 - 10.30 | Exhibition
opening and Coffee break |
10.00 - 10.30 | Exhibition & Coffee break | |||||||||||||
| SATELLITE
SYMPOSIA I The importance of initial antibiotic therapy |
SATELLITE
SYMPOSIA 3 Prevention of respiratory failure and improving quality of life in COPD |
|||||||||||||||
| 10.30 - 11.00 | The prevalence of extended spectrum beta lactamase and how to manage them | 10.30 - 11.00 | Pathophysiologic basis of hypercapnic respiratory failure in COPD | |||||||||||||
| 11.00 - 11.30 | Adequate AB therapy-Does it have close relation with mortality rate? | 11.00 - 11.30 | Oxygen therapy & non invasive ventilation in the management of respiratory failure in COPD patients | |||||||||||||
| 11.30 - 12.00 | Pharmacotherapies in the prevention and management of respiratory failure in COPD | |||||||||||||||
| SATELLITE
SYMPOSIA 2 Management of severe acute asthma and respiratory failure prevention |
||||||||||||||||
| 10.30 - 11.00 | Management challenges in severe & brittle asthma | SATELLITE
SYMPOSIA 4 Managing respiratory insufficiency following chemotherapy/radiotherapy/ lung resection |
||||||||||||||
| 11.00 - 11.30 | Life threatening exacerbation of asthma in emergency department: How to manage | 10.30 - 11.00 | The risk for acute lung injury/ acute respiratory distress syndrome after thoracic surgery of lung cancer | |||||||||||||
| 11.30 - 12.00 | Mechanical ventilation in severe asthma exacerbation | 11.00 - 11.30 | Acute respiratory distress syndrome after antineoplastic therapy and its management | |||||||||||||
| 11.30 - 12.00 | How to manage ARDS/ALI induced by thoracic radiation | |||||||||||||||
| LUNCH
SYMPOSIA 1 Sepsis prevention in pulmonary infections |
||||||||||||||||
| 12.00 - 12.20 | Early intervention of inflammatory cascade in sepsis: Is it possible? | LUNCH
SYMPOSIA 3 Respiratory infections in critical care |
||||||||||||||
| 12.20 - 12.40 | Microbiological resistance pattern in respiratory ICU & the choice of antibiotics | 12.00 - 12.15 | Severe respiratory infections in critical care unit. How to manage? | |||||||||||||
| 12.40 - 13.00 | Escalation & de-escalation therapy in the sepsis prevention/management due to pulmonary infection | 12.15 - 12.30 | Problems in the diagnosis of pulmonary fungal infection in intensive care unit and their management | |||||||||||||
| 12.30 - 12.45 | Aspiration pulmonary disease - diagnostic criteria and management in Japan | |||||||||||||||
| LUNCH
SYMPOSIA 2 Interventional procedures in lung cancer management |
||||||||||||||||
| 12.00 - 12.20 | Dyspnea in lung cancer | LUNCH
SYMPOSIA 4 Antibiotic and the lung |
||||||||||||||
| 12.20 - 12.40 | The role of broncoscopy in lung ca management | 12.00 - 12.15 | Choice of antibiotics in ARDS | |||||||||||||
| 12.40 - 13.00 | Surgical intervention in lung ca management | 12.15 - 12.30 | Penetration of vancomycin and linezolid into the lung | |||||||||||||
| 13.00 - 14.00 | Lunch | 12.30 - 12.45 | Strategies to prevent and manage sepsis due to respiratory infections | |||||||||||||
| 13.00-14.00 | Lunch | |||||||||||||||
| TRACK
SYMPOSIA 1 Hemodynamic monitoring, fluid and electrolytes management in ARDS |
||||||||||||||||
| 14.00 - 14.30 | Hemodynamic changes, fluid and electrolytes balance in acute respiratory distress syndrome | TRACK
SYMPOSIA 5 Applications of positive pressure and prone positioning in ARDS |
||||||||||||||
| 14.30 - 15.00 | The
effects of mechanical verfdlabon on hemodynamic and fluid balances |
14.00 -14.30 | Pulmonary dead space and survival in acute respiratory distress syndrome | |||||||||||||
| 15.00 - 15.30 | Transfusion-related
acute lung injury. How to prevent & manage |
14.30 - 15.00 | Airway pressures, tidal volumes, and mortality in patients with acute respiratory distress syndrome | |||||||||||||
| 15.00 -15.30 | Protective ventilation and prone position in the management of ARDS and prone positioning in acute respiratory distress syndrome | |||||||||||||||
| TRACK
SYMPOSIA 2 Prevention & management of respiratory failure in sleep disorders |
||||||||||||||||
14.00 -14.30 |
Surgical
management in obstructive sleep apnea |
TRACK
SYMPOSIA 6 Pharmacotherapies in prevention & management of ARDS |
||||||||||||||
| 14.30 - 15.00 | Obstructive sleep apnea and cardiovascular disease | 14.00 -14.30 | The effects of vasoactive drugs in improving oxygenisation | |||||||||||||
| 15.00 - 15.30 | Oxygen therapy and non invasive ventilation in sleep disorders | 14.30 - 15.00 | New strategies in the treatment of ARDS | |||||||||||||
| 15.00 -15.30 | Pro & cons of anticoagulant therapy in acute lung injury | |||||||||||||||
| TRACK
SYMPOSIA 3 Respiratory care in lung cancer management |
15.30-15.45 | CLOSING | ||||||||||||||
| 15.30 - 16.00 | Early detection of lung cancer: What can be done? | |||||||||||||||
| 16.00 - 16.30 | Respiratory care in lung cancer management | |||||||||||||||
| 16.30 - 17.00 | Pain management challenges in lung cancer | |||||||||||||||
| TRACK
SYMPOSIA 4 Corticosteroids in ARDS: To give or not to give |
||||||||||||||||
| 15.30 - 16.00 | Pro & cons: Corticosteroid in miliary & severe TB | |||||||||||||||
| 16.00 - 16.30 | Inflammatory cascades in ARDS | |||||||||||||||
| 16.30 - 17.00 | Pro & cons of corticosteroids in ARDS & critical illness: An evidence based review | |||||||||||||||
|
||||||||||||||||